Thinking of joining a study?

Register your interest

NCT05876091 | Recruiting | Tobacco-Related Carcinoma


Effects of Tobacco Flavoring and Liquid Composition on Vaping Topography
Sponsor:

Roswell Park Cancer Institute

Brief Summary:

This clinical trial tests the effect of tobacco flavor and liquid composition on the way a person puffs on a vape (topography). In general, tobacco products are designed with sensory factors in mind, such as flavor, to increase the appeal. Flavors and the composition of nicotine, either made in a lab (synthetic) or from tobacco, may create positive sensory effects, such as look, feel and taste, and influence smoking behavior and willingness to try different types of cigarettes. Understanding how nicotine vaping products are used is important in assessing individual and population level health risks. Vape flavors and synthetic nicotine may be related to harmful effects on health from vaping and may impact the appeal, risk beliefs and vaping topography.

Condition or disease

Tobacco-Related Carcinoma

Intervention/treatment

Vaping

Biospecimen Collection

Questionnaire Administration

Phase

Not Applicable

Detailed Description:

PRIMARY OBJECTIVE: I. Examine the influence of tobacco flavoring composition on vaping topography. II. Examine the influence of synthetic versus (vs.) tobacco derived nicotine on vaping topography. SECONDARY OBJECTIVE: I. Examine the influence of tobacco flavoring composition on vaping topography. II. Examine the influence of synthetic versus (vs.) tobacco derived nicotine on vaping topography. OUTLINE: The order of directed and ad libitum bouts are randomized within participants at each session. SESSION 1: Participants puff their own brand liquid on study. SESSIONS 2-5: Participants puff 1 of 4 randomly assigned tobacco flavor formulations at each visit on study. SESSIONS 6-7: Participants puff 1 of 2 randomly assigned nicotine formulations at each visit on study. Participants also undergo collection of saliva samples and optionally undergo collection of oral cell and oral rinse samples throughout study.}}

Study Type : Interventional
Estimated Enrollment : 72 participants
Masking : None (Open Label)
Primary Purpose : Prevention
Official Title : Effects of Tobacco Flavoring and Liquid Composition on Vaping Topography
Actual Study Start Date : August 30, 2023
Estimated Primary Completion Date : August 30, 2026
Estimated Study Completion Date : August 30, 2026
Arm Intervention/treatment

Experimental: Vaping -

Description The order of directed and ad libitum bouts are randomized within participants at each session. SESSION 1: Participants puff their own brand liquid on study. SESSIONS 2-5: Participants puff 1 of 4 randomly assigned tobacco flavor formulations at each visit on study. SESSIONS 6-7: Participants puff 1 of 2 randomly assigned nicotine formulations at each visit on study. Participants also undergo collection of saliva samples and optionally undergo collection of oral cell and oral rinse samples throughout study.

Other: Vaping

Procedure: Biospecimen Collection

Other: Questionnaire Administration

Ages Eligible for Study: 21 Years to 55 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Accepts Healthy Volunteers
Criteria
Inclusion Criteria
  • Current daily vapers of products containing nicotine
  • No daily concurrent use of other tobacco products
  • Self-reported general good health
  • Women of child bearing potential must be willing to provide a urine sample and test negative prior to receiving any study-related products/procedures
  • Participant must understand the investigational nature of this study and sign an independent ethics committee/institutional review board approved written informed consent form prior to receiving any study related procedure
Exclusion Criteria
  • Allergies - active untreated seasonal allergies that would interfere with smell or taste procedures
  • Self-reported taste or smell deficits
  • Pregnant or nursing female participants
  • Medications known to interfere with taste/smell (i.e.: certain nasal sprays, nasal antihistamines, decongestants, antibiotics, medications containing zinc)
  • Unwilling to use open system vaping device in laboratory setting
  • Positive diagnosis of human coronavirus 2019 infection (COVID-19) within 30 days prior to start of study intervention
  • Unwilling or unable to follow protocol requirements
  • Any condition which in the investigator's opinion deems the participant an unsuitable candidate to receive the study intervention

Effects of Tobacco Flavoring and Liquid Composition on Vaping Topography

Location Details


Please Choose a site



Effects of Tobacco Flavoring and Liquid Composition on Vaping Topography

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Recruiting

United States, New York

Roswell Park Comprehensive Cancer Center

Buffalo, New York, United States, 14263

Loading...